A COMPARISON OF XELIRI PLUS BEVACIZUMAB WITH FOLFIRI PLUS BEVACIZUMAB AS FIRST-LINE SETTING IN PATIENTS WITH METASTATIC COLORECTAL CANCER

Ahmet B., UYGUN K. , Kaya S., Ustaalioglu B. B. O. , Yildiz R., Temiz S., ...More

14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 - 30 June 2012, vol.23, pp.98-99 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 23
  • City: Barcelona
  • Country: Spain
  • Page Numbers: pp.98-99